Global Osteosarcoma Market Research Report 2022

Market Analysis and Insights: Global Osteosarcoma Market

An osteosarcoma (OS) is a cancerous tumor in a bone. Specifically, it is an aggressive malignant neoplasm that arises from primitive transformed cells of mesenchymal origin (and thus a sarcoma) and that exhibits osteoblastic differentiation and produces malignant osteoid. Osteosarcoma is the most common histological form of primary bone cancer. It is most prevalent in teenagers and young adults.

The global Osteosarcoma market size is projected to reach US$ 677.7 million by 2028, from US$ 518.2 million in 2021, at a CAGR of 3.5% during 2022-2028.

Osteosarcoma is the eighth-most common form of childhood cancer, comprising 2.4% of all malignancies in pediatric patients, and about 20% of all primary bone cancers. Incidence rates for osteosarcoma in U.S. patients under 20 years of age are estimated at 5.0 per million per year in the general population, with a slight variation between individuals of black, Hispanic, and white ethnicities (6.8, 6.5, and 4.6 per million per year, respectively). It is slightly more common in males (5.4 per million per year) than in females (4.0 per million per year).

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Osteosarcoma market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Osteosarcoma market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Osteosarcoma market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Osteosarcoma market.

Global Osteosarcoma Scope and Market Size

Osteosarcoma market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Osteosarcoma market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Intramedullary Osteosarcoma

Juxtacortical Osteosarcoma

Extraskeletal Osteosarcoma

Hospital

Clinic

Others

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Pfizer

Spectrum Pharmaceuticals

Hikma Pharmaceuticals

Baxter

Isofol

Advaxis

Bellicum Pharmaceuticals

Novartis

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Osteosarcoma Market Size Growth Rate by Type: 2017 VS 2021 VS 2028

1.2.2 Intramedullary Osteosarcoma

1.2.3 Juxtacortical Osteosarcoma

1.2.4 Extraskeletal Osteosarcoma

1.3 Market by Application

1.3.1 Global Osteosarcoma Market Share by Application: 2017 VS 2021 VS 2028

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2.1 Global Osteosarcoma Market Perspective (2017-2028)

2.2 Osteosarcoma Growth Trends by Region

2.2.1 Osteosarcoma Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Osteosarcoma Historic Market Size by Region (2017-2022)

2.2.3 Osteosarcoma Forecasted Market Size by Region (2023-2028)

2.3 Osteosarcoma Market Dynamics

2.3.1 Osteosarcoma Industry Trends

2.3.2 Osteosarcoma Market Drivers

2.3.3 Osteosarcoma Market Challenges

2.3.4 Osteosarcoma Market Restraints

3.1 Global Top Osteosarcoma Players by Revenue

3.1.1 Global Top Osteosarcoma Players by Revenue (2017-2022)

3.1.2 Global Osteosarcoma Revenue Market Share by Players (2017-2022)

3.2 Global Osteosarcoma Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Osteosarcoma Revenue

3.4 Global Osteosarcoma Market Concentration Ratio

3.4.1 Global Osteosarcoma Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Osteosarcoma Revenue in 2021

3.5 Osteosarcoma Key Players Head office and Area Served

3.6 Key Players Osteosarcoma Product Solution and Service

3.7 Date of Enter into Osteosarcoma Market

3.8 Mergers & Acquisitions, Expansion Plans

4.1 Global Osteosarcoma Historic Market Size by Type (2017-2022)

4.2 Global Osteosarcoma Forecasted Market Size by Type (2023-2028)

5.1 Global Osteosarcoma Historic Market Size by Application (2017-2022)

5.2 Global Osteosarcoma Forecasted Market Size by Application (2023-2028)

6.1 North America Osteosarcoma Market Size (2017-2028)

6.2 North America Osteosarcoma Market Size by Country (2017-2022)

6.3 North America Osteosarcoma Market Size by Country (2023-2028)

6.4 United States

6.5 Canada

7.1 Europe Osteosarcoma Market Size (2017-2028)

7.2 Europe Osteosarcoma Market Size by Country (2017-2022)

7.3 Europe Osteosarcoma Market Size by Country (2023-2028)

7.4 Germany

7.5 France

7.6 U.K.

7.7 Italy

7.8 Russia

7.9 Nordic Countries

8.1 Asia-Pacific Osteosarcoma Market Size (2017-2028)

8.2 Asia-Pacific Osteosarcoma Market Size by Country (2017-2022)

8.3 Asia-Pacific Osteosarcoma Market Size by Country (2023-2028)

8.4 China

8.5 Japan

8.6 South Korea

8.7 Southeast Asia

8.8 India

8.9 Australia

9.1 Latin America Osteosarcoma Market Size (2017-2028)

9.2 Latin America Osteosarcoma Market Size by Country (2017-2022)

9.3 Latin America Osteosarcoma Market Size by Country (2023-2028)

9.4 Mexico

9.5 Brazil

10.1 Middle East & Africa Osteosarcoma Market Size (2017-2028)

10.2 Middle East & Africa Osteosarcoma Market Size by Country (2017-2022)

10.3 Middle East & Africa Osteosarcoma Market Size by Country (2023-2028)

10.4 Turkey

10.5 Saudi Arabia

10.6 UAE

11.1 Pfizer

11.1.1 Pfizer Company Detail

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Osteosarcoma Introduction

11.1.4 Pfizer Revenue in Osteosarcoma Business (2017-2022)

11.1.5 Pfizer Recent Development

11.2 Spectrum Pharmaceuticals

11.2.1 Spectrum Pharmaceuticals Company Detail

11.2.2 Spectrum Pharmaceuticals Business Overview

11.2.3 Spectrum Pharmaceuticals Osteosarcoma Introduction

11.2.4 Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2017-2022)

11.2.5 Spectrum Pharmaceuticals Recent Development

11.3 Hikma Pharmaceuticals

11.3.1 Hikma Pharmaceuticals Company Detail

11.3.2 Hikma Pharmaceuticals Business Overview

11.3.3 Hikma Pharmaceuticals Osteosarcoma Introduction

11.3.4 Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2017-2022)

11.3.5 Hikma Pharmaceuticals Recent Development

11.4 Baxter

11.4.1 Baxter Company Detail

11.4.2 Baxter Business Overview

11.4.3 Baxter Osteosarcoma Introduction

11.4.4 Baxter Revenue in Osteosarcoma Business (2017-2022)

11.4.5 Baxter Recent Development

11.5 Isofol

11.5.1 Isofol Company Detail

11.5.2 Isofol Business Overview

11.5.3 Isofol Osteosarcoma Introduction

11.5.4 Isofol Revenue in Osteosarcoma Business (2017-2022)

11.5.5 Isofol Recent Development

11.6 Advaxis

11.6.1 Advaxis Company Detail

11.6.2 Advaxis Business Overview

11.6.3 Advaxis Osteosarcoma Introduction

11.6.4 Advaxis Revenue in Osteosarcoma Business (2017-2022)

11.6.5 Advaxis Recent Development

11.7 Bellicum Pharmaceuticals

11.7.1 Bellicum Pharmaceuticals Company Detail

11.7.2 Bellicum Pharmaceuticals Business Overview

11.7.3 Bellicum Pharmaceuticals Osteosarcoma Introduction

11.7.4 Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2017-2022)

11.7.5 Bellicum Pharmaceuticals Recent Development

11.8 Novartis

11.8.1 Novartis Company Detail

11.8.2 Novartis Business Overview

11.8.3 Novartis Osteosarcoma Introduction

11.8.4 Novartis Revenue in Osteosarcoma Business (2017-2022)

11.8.5 Novartis Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

    Table 1. Global Osteosarcoma Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028

    Table 2. Key Players of Intramedullary Osteosarcoma

    Table 3. Key Players of Juxtacortical Osteosarcoma

    Table 4. Key Players of Extraskeletal Osteosarcoma

    Table 5. Global Osteosarcoma Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028

    Table 6. Global Osteosarcoma Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

    Table 7. Global Osteosarcoma Market Size by Region (2017-2022) & (US$ Million)

    Table 8. Global Osteosarcoma Market Share by Region (2017-2022)

    Table 9. Global Osteosarcoma Forecasted Market Size by Region (2023-2028) & (US$ Million)

    Table 10. Global Osteosarcoma Market Share by Region (2023-2028)

    Table 11. Osteosarcoma Market Trends

    Table 12. Osteosarcoma Market Drivers

    Table 13. Osteosarcoma Market Challenges

    Table 14. Osteosarcoma Market Restraints

    Table 15. Global Osteosarcoma Revenue by Players (2017-2022) & (US$ Million)

    Table 16. Global Osteosarcoma Market Share by Players (2017-2022)

    Table 17. Global Top Osteosarcoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteosarcoma as of 2021)

    Table 18. Ranking of Global Top Osteosarcoma Companies by Revenue (US$ Million) in 2021

    Table 19. Global 5 Largest Players Market Share by Osteosarcoma Revenue (CR5 and HHI) & (2017-2022)

    Table 20. Key Players Headquarters and Area Served

    Table 21. Key Players Osteosarcoma Product Solution and Service

    Table 22. Date of Enter into Osteosarcoma Market

    Table 23. Mergers & Acquisitions, Expansion Plans

    Table 24. Global Osteosarcoma Market Size by Type (2017-2022) & (US$ Million)

    Table 25. Global Osteosarcoma Revenue Market Share by Type (2017-2022)

    Table 26. Global Osteosarcoma Forecasted Market Size by Type (2023-2028) & (US$ Million)

    Table 27. Global Osteosarcoma Revenue Market Share by Type (2023-2028)

    Table 28. Global Osteosarcoma Market Size by Application (2017-2022) & (US$ Million)

    Table 29. Global Osteosarcoma Revenue Market Share by Application (2017-2022)

    Table 30. Global Osteosarcoma Forecasted Market Size by Application (2023-2028) & (US$ Million)

    Table 31. Global Osteosarcoma Revenue Market Share by Application (2023-2028)

    Table 32. North America Osteosarcoma Market Size by Country (2017-2022) & (US$ Million)

    Table 33. North America Osteosarcoma Market Size by Country (2023-2028) & (US$ Million)

    Table 34. Europe Osteosarcoma Market Size by Country (2017-2022) & (US$ Million)

    Table 35. Europe Osteosarcoma Market Size by Country (2023-2028) & (US$ Million)

    Table 36. Asia-Pacific Osteosarcoma Market Size by Region (2017-2022) & (US$ Million)

    Table 37. Asia-Pacific Osteosarcoma Market Size by Region (2023-2028) & (US$ Million)

    Table 38. Latin America Osteosarcoma Market Size by Country (2017-2022) & (US$ Million)

    Table 39. Latin America Osteosarcoma Market Size by Country (2023-2028) & (US$ Million)

    Table 40. Middle East & Africa Osteosarcoma Market Size by Country (2017-2022) & (US$ Million)

    Table 41. Middle East & Africa Osteosarcoma Market Size by Country (2023-2028) & (US$ Million)

    Table 42. Pfizer Company Detail

    Table 43. Pfizer Business Overview

    Table 44. Pfizer Osteosarcoma Product

    Table 45. Pfizer Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 46. Pfizer Recent Development

    Table 47. Spectrum Pharmaceuticals Company Detail

    Table 48. Spectrum Pharmaceuticals Business Overview

    Table 49. Spectrum Pharmaceuticals Osteosarcoma Product

    Table 50. Spectrum Pharmaceuticals Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 51. Spectrum Pharmaceuticals Recent Development

    Table 52. Hikma Pharmaceuticals Company Detail

    Table 53. Hikma Pharmaceuticals Business Overview

    Table 54. Hikma Pharmaceuticals Osteosarcoma Product

    Table 55. Hikma Pharmaceuticals Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 56. Hikma Pharmaceuticals Recent Development

    Table 57. Baxter Company Detail

    Table 58. Baxter Business Overview

    Table 59. Baxter Osteosarcoma Product

    Table 60. Baxter Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 61. Baxter Recent Development

    Table 62. Isofol Company Detail

    Table 63. Isofol Business Overview

    Table 64. Isofol Osteosarcoma Product

    Table 65. Isofol Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 66. Isofol Recent Development

    Table 67. Advaxis Company Detail

    Table 68. Advaxis Business Overview

    Table 69. Advaxis Osteosarcoma Product

    Table 70. Advaxis Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 71. Advaxis Recent Development

    Table 72. Bellicum Pharmaceuticals Company Detail

    Table 73. Bellicum Pharmaceuticals Business Overview

    Table 74. Bellicum Pharmaceuticals Osteosarcoma Product

    Table 75. Bellicum Pharmaceuticals Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 76. Bellicum Pharmaceuticals Recent Development

    Table 77. Novartis Company Detail

    Table 78. Novartis Business Overview

    Table 79. Novartis Osteosarcoma Product

    Table 80. Novartis Revenue in Osteosarcoma Business (2017-2022) & (US$ Million)

    Table 81. Novartis Recent Development

    Table 82. Research Programs/Design for This Report

    Table 83. Key Data Information from Secondary Sources

    Table 84. Key Data Information from Primary Sources

List of Figures

    Figure 1. Global Osteosarcoma Market Share by Type: 2021 VS 2028

    Figure 2. Intramedullary Osteosarcoma Features

    Figure 3. Juxtacortical Osteosarcoma Features

    Figure 4. Extraskeletal Osteosarcoma Features

    Figure 5. Global Osteosarcoma Market Share by Application in 2021 & 2028

    Figure 6. Hospital Case Studies

    Figure 7. Clinic Case Studies

    Figure 8. Others Case Studies

    Figure 9. Osteosarcoma Report Years Considered

    Figure 10. Global Osteosarcoma Market Size (US$ Million), Year-over-Year: 2017-2028

    Figure 11. Global Osteosarcoma Market Size, (US$ Million), 2017 VS 2021 VS 2028

    Figure 12. Global Osteosarcoma Market Share by Region: 2021 VS 2028

    Figure 13. Global Osteosarcoma Market Share by Players in 2021

    Figure 14. Global Top Osteosarcoma Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteosarcoma as of 2021)

    Figure 15. The Top 10 and 5 Players Market Share by Osteosarcoma Revenue in 2021

    Figure 16. North America Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 17. North America Osteosarcoma Market Share by Country (2017-2028)

    Figure 18. United States Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 19. Canada Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 20. Europe Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 21. Europe Osteosarcoma Market Share by Country (2017-2028)

    Figure 22. Germany Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 23. France Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 24. U.K. Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 25. Italy Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 26. Russia Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 27. Nordic Countries Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 28. Asia-Pacific Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 29. Asia-Pacific Osteosarcoma Market Share by Region (2017-2028)

    Figure 30. China Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 31. Japan Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 32. South Korea Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 33. Southeast Asia Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 34. India Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 35. Australia Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 36. Latin America Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 37. Latin America Osteosarcoma Market Share by Country (2017-2028)

    Figure 38. Mexico Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 39. Brazil Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 40. Middle East & Africa Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 41. Middle East & Africa Osteosarcoma Market Share by Country (2017-2028)

    Figure 42. Turkey Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 43. Saudi Arabia Osteosarcoma Market Size YoY Growth (2017-2028) & (US$ Million)

    Figure 44. Pfizer Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 45. Spectrum Pharmaceuticals Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 46. Hikma Pharmaceuticals Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 47. Baxter Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 48. Isofol Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 49. Advaxis Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 50. Bellicum Pharmaceuticals Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 51. Novartis Revenue Growth Rate in Osteosarcoma Business (2017-2022)

    Figure 52. Bottom-up and Top-down Approaches for This Report

    Figure 53. Data Triangulation

    Figure 54. Key Executives Interviewed